SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans

Por Lazaar, Aili L, Sweeney, Lisa E, MacDonald, Alexander J, Alexis, Neil E, Chen, Chao, Tal-Singer, Ruth
Publicado em 2011